Here are nine key notes from orthopedic and spine device companies in the past week.
DePuy Synthes, a Johnson & Johnson company, reported $2.2 billion in sales for the second quarter of 2018.
Medtronic reported flat first quarter revenue at $7.3 billion and a slight increase in spine revenue to $652 million.
Xtant Medical appointed Kathie Lenzen CFO.
A federal appeals court decision last week will prolong the tax accounting dispute between Medtronic and the IRS, which is already more than a decade old.
SPR Therapeutics earned FDA clearance for its Sprint endura and extensa Peripheral Nerve Stimulation Systems.
KFx Medical filed a lawsuit against Stryker, alleging patent infringement on the knotless double row rotator cuff repair procedure.
NuVasive appointed Dale Wolf as the vice president of manufacturing.
Tarek Elalayli, MD, was the first surgeon to perform a spinal fusion using Amedica's Valeo C+CSC with Lumen Interbody Fusion Device.
CoreLink received FDA clearance to market its Foundation 3D Anterior Lumbar Interbody device.